References
- Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet Lond Engl. 2021;397:1301–1315. doi:10.1016/S0140-6736(20)32549-6
- Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31:205–212. doi:10.1111/jdv.13854
- Ding X, Wang T, Shen Y, et al. Prevalence of psoriasis in China: a population-based study in six cities. Eur J Dermatol. 2012;22:663–667. doi:10.1684/ejd.2012.1802
- Bell KA, Balogh EA, Feldman SR. An update on the impact of depression on the treatment of psoriasis. Expert Opin Pharmacother. 2021;22:695–703. doi:10.1080/14656566.2020.1849141
- Jalenques I, Bourlot F, Martinez E, et al. Prevalence and odds of anxiety disorders and anxiety symptoms in children and adults with psoriasis: systematic review and meta-analysis. Acta Derm Venereol. 2022;102:adv00769. doi:10.2340/actadv.v102.1386
- Jing D, Xiao H, Shen M, et al. Association of psoriasis with anxiety and depression: a case-control study in Chinese patients. Front Med. 2021;8:771645. doi:10.3389/fmed.2021.771645
- Dowlatshahi EA, Wakkee M, Arends LR, Nijsten T. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J Invest Dermatol. 2014;134:1542–1551. doi:10.1038/jid.2013.508
- Fleming P, Bai JW, Pratt M, et al. The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials. J Eur Acad Dermatol Venereol. 2017;31:798–807. doi:10.1111/jdv.13891
- Nadeem A, Ahmad SF, Al-Harbi NO, et al. IL-17A causes depression-like symptoms via NFκB and p38MAPK signaling pathways in mice: implications for psoriasis associated depression. Cytokine. 2017;97:14–24. doi:10.1016/j.cyto.2017.05.018
- Elmets CA, Leonardi CL, Davis DMR, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol. 2019;80(4):1073–1113. doi:10.1016/j.jaad.2018.11.058
- Singh P, Silverberg JI. Underscreening of depression in U.S. outpatients with atopic dermatitis and psoriasis. Br J Dermatol. 2020;182:1057–1059. doi:10.1111/bjd.18629
- Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71:171–186. doi:10.1097/PSY.0b013e3181907c1b
- Bianciardi E, Barone Y, Lo Serro V, et al. Inflammatory markers of perinatal depression in women with and without history of trauma. Riv Psichiatr. 2021;56:237–245. doi:10.1708/3681.36671
- Liukkonen T, Räsänen P, Jokelainen J, et al. The association between anxiety and C-reactive protein (CRP) levels: results from the Northern Finland 1966 birth cohort study. Eur Psychiatry J Assoc Eur Psychiatr. 2011;26(6):363–369. doi:10.1016/j.eurpsy.2011.02.001
- Helliwell PS, Taylor WJ. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis. 2005;64(Suppl 2):ii3–8. doi:10.1136/ard.2004.032318
- Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613. doi:10.1046/j.1525-1497.2001.016009606.x
- Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–1097. doi:10.1001/archinte.166.10.1092
- Fredriksson T, Pettersson U. Severe psoriasis--oral therapy with a new retinoid. Dermatologica. 1978;157:238–244. doi:10.1159/000250839
- Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–216. doi:10.1111/j.1365-2230.1994.tb01167.x
- Ye X, Shu H-L, Feng X, et al. Reliability and validity of the Chinese version of the Patient Health Questionnaire-9 (C-PHQ-9) in patients with psoriasis: a cross-sectional study. BMJ Open. 2020;10(7):e033211. doi:10.1136/bmjopen-2019-033211
- Liu Z-W, Yu Y, Hu M, et al. PHQ-9 and PHQ-2 for screening depression in Chinese rural elderly. PLoS One. 2016;11(3):e0151042. doi:10.1371/journal.pone.0151042
- Tong X, An D, McGonigal A, Park S-P, Zhou D. Validation of the Generalized Anxiety Disorder-7 (GAD-7) among Chinese people with epilepsy. Epilepsy Res. 2016;120:31–36. doi:10.1016/j.eplepsyres.2015.11.019
- Felger JC, Li Z, Haroon E, et al. Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry. 2016;21(10):1358–1365. doi:10.1038/mp.2015.168
- Michos ED, McEvoy JW, Blumenthal RS, Jarcho JA. Lipid management for the prevention of atherosclerotic cardiovascular disease. N Engl J Med. 2019;381:1557–1567. doi:10.1056/NEJMra1806939
- Chen CM. Overview of obesity in Mainland China. Obes Rev off J Int Assoc Study Obes. 2008;9(Suppl 1):14–21. doi:10.1111/j.1467-789X.2007.00433.x
- Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–35. doi:10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
- Hu -SC-S, Chen G-S, Tu H-P. Epidemiology of depression in patients with psoriasis: a nationwide population-based cross-sectional study. Acta Derm Venereol. 2019;99:530–538. doi:10.2340/00015555-3145
- Liu S, Yang L, Zhang C, et al. Online mental health services in China during the COVID-19 outbreak. Lancet Psychiatry. 2020;7(4):e17–e18. doi:10.1016/S2215-0366(20)30077-8
- Zhai Y, Du X. Mental health care for international Chinese students affected by the COVID-19 outbreak. Lancet Psychiatry. 2020;7:e22. doi:10.1016/S2215-0366(20)30089-4
- Hölsken S, Krefting F, Schedlowski M, Sondermann W. Common fundamentals of psoriasis and depression. Acta Derm Venereol. 2021;101:adv00609. doi:10.2340/actadv.v101.565
- Li F, Ai W, Ye J, et al. Inflammatory markers and risk factors of RA patients with depression and application of different scales in judging depression. Clin Rheumatol. 2022;41:2309–2317. doi:10.1007/s10067-022-06174-3
- Shan -L-L, Wang Y-L, Qiao T-C, et al. Association of serum interleukin-8 and serum amyloid A with anxiety symptoms in patients with cerebral small vessel disease. Front Neurol. 2022;13:938655. doi:10.3389/fneur.2022.938655
- Tang C-Z, Zhang Y-L, Wang W-S, Li W-G, Shi J-P. Serum levels of high-sensitivity c-reactive protein at admission are more strongly associated with poststroke depression in acute ischemic stroke than homocysteine levels. Mol Neurobiol. 2016;53:2152–2160. doi:10.1007/s12035-015-9186-2
- Chang HH, Wang T-Y, Lee IH, et al. C-reactive protein: a differential biomarker for major depressive disorder and bipolar II disorder. World J Biol Psychiatry. 2017;18:63–70. doi:10.3109/15622975.2016.1155746
- Cheng L-S, Tu W-J, Shen Y, Zhang L-J, Ji K. Combination of high-sensitivity C-reactive protein and homocysteine predicts the post-stroke depression in patients with ischemic stroke. Mol Neurobiol. 2018;55:2952–2958. doi:10.1007/s12035-017-0549-8